Ticker | $ Bought |
---|---|
intra-cellular therapies inc | 403,016,000 |
somnigroup international inc | 79,415,400 |
verona pharma plc | 68,886,000 |
alkermes plc | 45,891,200 |
abbott labs | 44,172,400 |
beta bionics inc | 40,786,400 |
cardinal health inc | 37,611,200 |
joyy inc | 32,744,400 |
Ticker | % Inc. |
---|---|
healthequity inc | 14,964 |
globus med inc | 2,205 |
ge healthcare technologies i | 333 |
vnet group inc | 275 |
flutter entmt plc | 167 |
forte biosciences inc | 101 |
salesforce inc | 62.55 |
genedx holdings corp | 55.38 |
Ticker | % Reduced |
---|---|
healthcare rlty tr | -99.63 |
arrowhead pharmaceuticals in | -97.49 |
dyne therapeutics inc | -95.64 |
soleno therapeutics inc | -94.44 |
silicon motion technology co | -92.94 |
zymeworks inc | -69.92 |
full truck alliance co ltd | -55.64 |
biodesix inc | -51.22 |
Ticker | $ Sold |
---|---|
zto express cayman inc | -54,598,100 |
hashicorp inc | -220,757,000 |
matterport inc | -24,027,500 |
elevation oncology inc | -1,984,560 |
bristol-myers squibb co | -180,313,000 |
airbnb inc | -319,221,000 |
endeavor group hldgs inc | -57,422,900 |
gds hldgs ltd | -36,379,700 |
FARALLON CAPITAL MANAGEMENT LLC has about 46.7% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 46.7 |
Technology | 17.2 |
Industrials | 10 |
Financial Services | 8.3 |
Communication Services | 8 |
Others | 5.5 |
Real Estate | 2.1 |
Consumer Defensive | 1.5 |
FARALLON CAPITAL MANAGEMENT LLC has about 60% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
LARGE-CAP | 39.4 |
MID-CAP | 32.9 |
MEGA-CAP | 20.6 |
UNALLOCATED | 5.5 |
SMALL-CAP | 1.3 |
About 71% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
S&P 500 | 52.1 |
Others | 29 |
RUSSELL 2000 | 18.9 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
FARALLON CAPITAL MANAGEMENT LLC has 132 stocks in it's portfolio. About 36% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. EXEL was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 15 May, 2025Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ABC | cencora inc | 0.00 | 1,000 | 278,090 | unchanged | 0.00 | ||
ABNB | airbnb inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
ABT | abbott labs | 0.25 | 333,000 | 44,172,400 | new | |||
ACLX | arcellx inc | 0.00 | 4,000 | 262,400 | unchanged | 0.00 | ||
ADI | analog devices inc | 1.49 | 1,327,000 | 267,616,000 | added | 14.67 | ||
ADSK | autodesk inc | 2.92 | 1,997,400 | 522,919,000 | added | 8.45 | ||
AGIO | agios pharmaceuticals inc | 0.93 | 5,700,470 | 167,024,000 | added | 0.46 | ||
ALKS | alkermes plc | 0.26 | 1,389,800 | 45,891,200 | new | |||
ALT | altimmune inc | 0.00 | 27,600 | 138,000 | unchanged | 0.00 | ||
ALTR | altair engr inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AON | aon plc | 2.11 | 1,361,740 | 378,337,000 | reduced | -25.7 | ||
ARDX | ardelyx inc | 0.00 | 23,000 | 112,930 | unchanged | 0.00 | ||
ARMK | aramark | 3.13 | 16,242,000 | 560,674,000 | added | 42.34 | ||
ARQT | arcutis biotherapeutics inc | 0.00 | 26,000 | 406,640 | unchanged | 0.00 | ||
ARWR | arrowhead pharmaceuticals in | 0.00 | 15,800 | 201,292 | reduced | -97.49 | ||
AXSM | axsome therapeutics inc | 0.00 | 4,000 | 466,520 | unchanged | 0.00 | ||
BBIO | bridgebio pharma inc | 1.10 | 5,731,000 | 198,121,000 | added | 36.62 | ||
BDSX | biodesix inc | 0.01 | 1,859,310 | 1,162,440 | reduced | -51.22 | ||
BEAM | beam therapeutics inc | 1.08 | 9,928,110 | 193,896,000 | added | 20.5 | ||
BGNE | beigene ltd | 0.00 | 1,100 | 299,387 | unchanged | 0.00 | ||